Our stories

We are patients, we are donors, we are a community, we are humans.

Discover all stories
People
Diane’s story: a long journey to a Primary Immunedeficiencies diagnosis
Watch
Awareness
GBS and CIDP: giving voice to awareness, from lived experience to care
Watch
Awareness
Breaking taboos and closing gaps: women’s health in focus
Watch
Awareness
Looking beyond labels: understanding the connection between Primary and Secondary Immunodeficiencies
Watch
NEWS

Discover our press releases, media resources, event information and stay updated on the latest news.

Fostering dialogue between industry and European institutions 29-05-2026 Fostering dialogue between industry and European institutions Read the news
EMA grants Orphan Drug Designation to Kedrion’s Factor V program 27-05-2026 EMA grants Orphan Drug Designation to Kedrion’s Factor V program Read the news
€150 million investment to triple Kedrion’s production capacity: Italy's “Plasma Valley” to treat rare diseases 11-05-2026 €150 million investment to triple Kedrion’s production capacity: Italy's “Plasma Valley” to treat rare diseases Read the news
Kedrion at IPPC 2026: driving the conversation across the plasma ecosystem 27-04-2026 Kedrion at IPPC 2026: driving the conversation across the plasma ecosystem Read the news
Kedrion delivers strong financial performance in 2025 20-04-2026 Kedrion delivers strong financial performance in 2025 Read the news
2025 Annual Report - The Chain of Care
From those who donate, to our work in operations and research, to the experiences of patients, communities, and our people.

A year of growth and progress, marked by key milestones and a continued focus on what matters most.

Real stories across the Chain.

👉 Explore the Report!
Read more
The 2025 Sustainability Report is here!
Discover how we are making strides in sustainability and creating rare connections that impact millions of lives. Learn about our efforts in reducing our carbon footprint, conserving water, and fostering diversity and innovation.

Click "read more" to explore our journey and achievements.
Read more
shield (1)
Pharmacovigilance
genetics (1)
Medical & Scientific Information